Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-09-16 to 2022-05-15
Current total value of award: $299275
Description: SBIR PHASE I TOPIC 392: TARGETED RADIONUCLIDE THERAPY OF METASTATIC LIVER CANCER